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Chemical	Experimental	-	General	Information	
	
Chemical	 reagents	were	purchased	 from	Sigma-Aldrich,	 Fluka,	Acros,	Novabiochem,	 and	Bachem.	 Peptide	
grade	 DMF	 was	 purchased	 from	 Rathburn	 Chemicals.	 Anhydrous	 DCM	 was	 obtained	 by	 distillation	 over	
calcium	 hydride.	 	 Analytical	 TLC	 was	 performed	 using	 silica	 gel	 60	 F254	 pre-coated	 on	 aluminium	 sheets	
(Merck).	 Column	 chromatography	was	 performed	 on	 silica	 gel	 60	 (35-70	micron)	 from	 Sigma-Aldrich.	 UV	
spectra	were	recorded	on	a	Perkin-Elmer	Lambda	19	uv/vis	spectrophotometer.	Fluorescence	spectra	were	
recorded	 on	 a	 Cary	 Eclipse	 fluorimeter.	 1H	 and	 13C	 NMR	 were	 recorded	 using	 a	 Varian	 Mercury-VX	
spectrometer	at	400	MHz	(1H)	and	100	MHz	(13C)	or	a	Bruker	Avance	III	500	at	500	MHz	(1H)	and	125	MHz	
(13C).	Chemical	shift	values	are	given	in	ppm	(δ).	J	values	are	given	in	Hz.	Analytical	RP-HPLC	was	performed	
on	a	Dionex	Ultimate	3000	system	(Dionex,	UK),	with	a	VWD-3400	variable	wavelength	detector,	and	a	RF-
2000	fluorescence	detector.	Analyses	were	performed	at	35	±	0.1	°C	on	a	Gemini	5	μ	C18	110A	column,	(150	
x	 4.6	 mm	 -	 Phenomenex,	 UK),	 equipped	 with	 a	 Security	 Guard	 C18	 (ODS)	 4	 x	 3.0	 mm	 ID	 guard	 column	
(Phenomenex,	UK),	at	a	flow	rate	of	1	mL/min.	Mobile	phase	A	was	0.1%	aq.	TFA,	mobile	phase	B	was	0.1%	
TFA	in	MeCN.	(Gradient:	0.0–10.0	min	0-95%	B,	10.0–20.0	min	95%	B,	20.0–20.1	min	at	95-5%	B,	20.1–23.0	
min	 5%	 B).	 Preparative	 RP-HPLC	was	 performed	 on	 a	 Dionex	HPLC	 system	 equipped	with	 a	 Phenomenex	
Gemini	5	μ	C18	(250	x	10w	mm)	column	at	a	flow	rate	of	2.5	mL/min.	High	resolution	mass	spectrometry	was	
performed	using	a	Bruker	MicroTOF	autospec	ESI	mass	spectrometer.	
	
131-Ethylenediaminylchlorin	e6	dimethyl	ester	(1)	
	
Methyl	 pheophorbide	 a	 was	 prepared	 by	 extraction	 and	 purification	 of	 pheophytin	 a	 from	 Spirulina	 spp.	
followed	 by	 methanolysis	 of	 the	 phytol	 group.1	 A	 solution	 of	 pheophorbide	 a	 (100	 mg,	 0.17	 mmol)	 in	
anhydrous	THF	(25	mL)	was	treated	with	1,2-diaminoethane	(397	μL,	5.94	mmol,	36	eq).	The	resulting	solution	
was	stirred	at	room	temperature	overnight.	The	mixture	was	then	diluted	with	DCM	(100	mL)	and	washed	
with	H2O	(3	x	50	mL)	and	brine	(50	mL).	The	organic	phase	was	dried	(Na2SO4)	and	the	solvent	was	evaporated.	
The	crude	product	(107	mg,	quant.)	was	used	without	further	purification.		A	sample	was	purified	by	column	
chromatography,	 eluting	 first	 with	 2.5%	MeOH/DCM,	 then	 50%	MeOH/DCM.	 The	 spectroscopic	 data	 (1H	
NMR)	was	consistent	with	the	literature.2	1H-NMR	(400	MHz,	(CD3)2CO)	9.86	(s,	1H),	9.79	(s,	1H),	9.12	(s,	1H),	
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8.29	(dd,	J	=	17.9,	11.6,	1H),	6.46	(dd,	J	=	11.6,	1.5,	1H),	6.19	(dd,	J	=	11.6,	1.5,	1H),	5.64	(d,	J	=	19.0,	1H),	5.41	
(d,	J	=	19.0,	1H),	4.68	(q,	J	=	7.2,	1H),	4.54	(q,	J	=	10.1,	1H),	4.19-4.11	(m,	1H),	4.06-3.97	(m,	2H),	3.87	(q,	J	=	
7.6,	2H),	3.80-3.50	(m,	14H),	3.36	(s,	3H),	2.77-2.66	(m,	obsc,	1H),	2.39-2.30	(m,	4H),	1.78-1.71	(m,	6H),	-1.53	
(s,	0.5H),	-1.84	(s,	0.5H)	
		
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1.	1H	NMR	in	(CD3)2CO	of	1.	
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131-[4-(3-maleimido)-propanoylamido]ethylamidochlorin	e6	dimethyl	ester	(2)	
	
A	solution	of	1	(444	mg,	0.666	mmol)	in	dry	DCM	(30	mL)	was	treated	with	3-maleimidopropanoic	acid	(124	mg,	0.733	
mmol),	EDC	(153	mg,	0.799	mmol),	HOBt	 (108	mg,	0.799	mmol)	and	DIPEA	(346	µL,	2.00	mmol).	The	mixture	was	
stirred	at	room	temperature	overnight,	then	it	was	diluted	with	DCM	(100	mL)	and	was	washed	with	H2O	(100	mL)	and	
brine	(100	mL).	The	organic	phase	was	dried	(Na2SO4),	filtered,		and	the	solvent	was	evaporated.	The	crude	product	
was	purified	by	column	chromatography	(MeOH/EtOAc	gradient).	This	gave	2	as	a	dark	green	solid	(422	mg,	80%)	Rf	
(EtOAc)	 =	 0.17;	 Rt	 HPLC:	 8.97	min;	 UV-vis	 (CHCl3),	 nm	 (%):	 404	 (100),	 511	 (8.0),	 534	 (5.2),	 610	 (5.9),	 665	 (32.7);	
fluorescence	λmax.	(CHCl3,	λexc.	=	405	nm)	671	nm;		1H-NMR	(400	MHz,	CDCl3)	9.69	(s,	1H),	9.57	(s,	1H),	8.85	(s,	1H),	7.98	
(t,	J	=	14.5,	1H),	6.87	(br,	1H),	6.27	(d,	J	=	17.9,	1H),	6.09	(d,	J	=	11.5,	1H),	5.95	(s,	2H),	5.49	(d,	J	=	18.4,	1H),	5.18	(d,	J	=	
18.7,	1H),	4.49	(d,	J	=	7.3,	1H),	4.41	(d,	J	=	9.7,	1H),	3.79-3.55	(m,	9H),	3.27-3.51	(m,	6H),	3.14-3.21	(m,	2H),	2.62-2.50	
(m,	1H),	2.13-2.36	(m,	3H),	1.81-1.51	(m,	7H),	1.42-1.16	(m,	6H),	0.94-0.76	(m,	2H),	-1.83	(br,	1H),	-1.95	(br,	2H);	13C-
NMR	(100	MHz,	CDCl3)	174.2,	173.6,	170.8,	170.4,	169.9,	134.9,	133.8,	130.7,	129.3,	122.3,	101.4,	98.8,	94.3,	75.7,	
53.2,	52.4,	51.8,	49.3,	40.1,	39.7,	38.0,	34.8,	34.3,	32.0,	31.5,	31.2,	30.4,	30.3,	29.8,	29.5,	27.8,	27.2,	26.3,	23.2,	22.8,	
19.7,	17.7,	14.2,	12.2,	12.1,	11.4;	HRMS	[found	(ESI+)	818.3875	[M+H]+],	calcd.	for	C45H52N7O8:	818.3872].		
	
	
	
	
	
	
	
	
	
	
	
Figure	2.	1H	NMR	in	CDCl3	of	2.	
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Figure	3	(a)	13C	NMR	in	CDCl3	of	2;	(b)	HPLC	profile	of	2;	(c)	UV-visible	(solid	line)	and	fluorescence	(dotted	line)	
spectra	in	CHCl3	for	2,	(d)	ESI-MS	for	2.	
	
(a)	
(b)	
(c)	
(d)	
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131-[(6-dibenzoazacyclooctynecaproateamido)ethylamidochlorin	e6	dimethyl	ester	(3)	
	
A	 solution	 of	 1	 (22.0	 mg,	 0.033	 mmol)	 in	 dry	 DCM	 (1	 mL)	 was	 treated	 with	 HOBt	 (4.9	 mg,	 0.036	 mmol),	
dibenzocyclooctyne-acid	(10.0	mg,	0.030	mmol),	EDC.HCl	(6.9	mg,	0.036	mmol)	and	DIPEA	(15.6	μL,	0.09	mmol).	 in	
anhydrous	DCM	(1	mL).	The	mixture	was	stirred	at	room	temperature	overnight,	then	the	solvent	was	evaporated	and	
the	crude	product	was	purified	directly	by	column	chromatography,	eluting	with	EtOAc.	This	gave	3	as	a	green	solid	
(13	mg,	44	%);	Rf	(EtOAc)	=	0.23;	Rt	(HPLC)	=	10.36	min;	UV-vis:	λmax	nm	(%):	404	(100),	489	(10.0),	609	(4.2),	665	(32.9);	
fluorescence	λmax.	(λexc.	=	420	nm)	667	nm;	1H-NMR	(500	MHz,	DMSO-d6,	60°C)		9.83	(br,	1	H),	9.78	(br,	1	H),	9.13	(br,	1	
H),	8.94	(br,	1	H),	8.29	(dd,	J	=	17.8,	11.6,	1	H),	7.73	(br,	1	H),	7.66	-	7.25	(m,	8	H),	6.46	(d,	J	=	17.8,	1	H),	6.21	(d,	J	=	
11.6,	1	H),	5.53	(d,	J	=	18.8,	1	H),	5.31	(d,	J	=	18.8	Hz,	1	H),	5.10	-	5.01	(m,	1	H),	4.63	(d,	J	=	7.1	Hz,	1	H),	4.45	(d,	J	=	10.4,	
1	H),	3.90-3.81	(m,	2	H),	3.73-3.65	(m,	4	H),	3.63-3.43	(m,	12	H),	3.38	-	3.29	(m,	3	H),	2.74	-	2.60	(m,	1	H),	2.37	-	2.26	
(m,	1	H),	2.24-2.11	(m,	2	H),	2.04	-	1.94	(m,	2	H),	1.88	-	1.76	(m,	1	H),	1.73	-	1.60	(m,	7	H),	1.44	-	1.18	(m,	6	H),	-2.15	-	-
1.70	(m,	2	H);	13C-NMR	(125	MHz,	DMSO-d6,	60°C)		174.3,	173.5,	173.1,	172.6,	172.1,	168.6,	168.4,	152.4,	148.9,	144.6,	
138.9,	136.3,	134.4,	132.8,	130.8,	130.5,	130.2,	129.8,	129.2,	128.5,	128.4,	128.0,	127.2,	125.5,	123.0,	122.6,	122.0,	
114.9,	108.6,	103.6,	101.2,	98.9,	94.9,	79.7,	79.4,	79.2,	55.3,	53.3,	52.2,	51.7,	48.7,	38.8,	37.5,	35.7,	34.4,	34.2,	33.8,	
31.1,	30.0,	25.1,	25.0,	24.8,	24.3,	23.4,	19.4,	18.0,	12.4,	12.1,	11.4;	HRMS	[found	(ESI+):	982.4995	[M+H]+,	calcd.	for	
C59H63N7O7:	982.4862].		
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Figure	4	(a)	1H	NMR	and	(b)	13C	NMR	in	DMSO-d6	of	3.	
	
	
(a)	
(b)	
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Figure	5	(a)	HPLC	profile	of	3;	(b)	UV-visible	(solid	line)	and	fluorescence	(dotted	line)	spectra	in	CHCl3	for	3;	(c)	ESI-
MS	for	3.	
	
	
	
	 	
(c)	
(a)	 (b)	
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Ce6-Tat	conjugate	(7)	–	N-terminal	thiol	maleimide	ligation	(Ce6	refers	to	chlorin	e6)	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	6	(a)	HPLC	profile	of	7;	(b)	UV-visible	(solid	line)	and	fluorescence	(dotted	line)	spectra	in	0.1%	aq.	TFA	for	7;	
(c)	ESI-MS	for	7.	
	 	
(a)	
(c)	
(b)	
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Ce6-Tat	conjugate	(8)	–	C-terminal	thiol	maleimide	ligation	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	7	(a)	HPLC	profile	of	8;	(b)	UV-visible	(solid	line)	and	fluorescence	(dotted	line)	spectra	in	0.1%	aq.	TFA	for	8;	
(c)	ESI-MS	for	8.	
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(b)	
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Ce6-Tat	conjugate	(9)	–	N-terminal	SPAAC	ligation	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	8	(a)	HPLC	profile	of	9;	(b)	UV-visible	(solid	line)	and	fluorescence	(dotted	line)	spectra	in	0.1%	aq.	TFA	for	9;	
(c)	ESI-MS	for	9.	
	
	
	
	
	
(a)	 (b)	
(c)	
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Singlet	oxygen	quenching	using	sodium	azide		
To	confirm	that	the	detected	singlet	oxygen	(1O2)	phosphorescence	curve	was	due	to	the	decay	curve	of	1O2,	different	
concentrations	of	NaN3	were	added	to	solutions	of	chlorin	e6	conjugates	(7	and	8),	dissolved	in	deuterated	methanol	
and	the	1270	nm	decay	kinetics	 for	each	sample	solution	was	measured.	As	shown	 in	Figure	8,	 the	 1O2	signal	was	
strongly	 quenched,	 on	 addition	 of	 NaN3,	 consistent	with	 the	 detected	 signal	 being	 due	 to	 singlet	 oxygen.	 This	 is	
consistent	with	the	rapid	physical	quenching	of	singlet	oxygen	by	azide	ions.3		
	
	
Figure	9	Time-resolved	singlet	oxygen	phosphorescence	signal	recorded	upon	excitation	of	conjugate	at	532	nm	with	
increasing	NaN3	concentrations,		showing	quenching	of	phosphorescence	by	azide	ions		(A:	conjugate	7,	B:	conjugate	
8)	
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